These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6199337)

  • 1. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
    Shackelford DA; Strominger JL
    Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional gel electrophoretic analysis of the MT3 and DR4 molecules from the different D-typed cells.
    Suzuki M; Yabe T; Satake M; Juji T; Hamaguchi H
    J Exp Med; 1984 Sep; 160(3):751-8. PubMed ID: 6206187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of three class II antigens from a homozygous human B cell line.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the MT3 molecule using two-dimensional gel electrophoresis and alloantisera.
    Suzuki M; Maeda H; Mukai R; Yabe T; Hamaguchi H
    Immunogenetics; 1983; 18(6):575-83. PubMed ID: 6197369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the HLA-DRw9 antigen using two-dimensional gel electrophoresis and alloantisera.
    Yabe T; Suzuki M; Mukai R; Satake M; Juji T; Hamaguchi H
    Jinrui Idengaku Zasshi; 1984 Mar; 29(1):17-25. PubMed ID: 6205188
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation of four class II molecules from DR2 and DRw6 homozygous B lymphoid cell lines.
    Maeda H; Hirata R
    Immunogenetics; 1984; 20(6):639-47. PubMed ID: 6392082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a human Ia antigen that is different from HLA-DR and DC antigens.
    Makgoba MW; Hildreth JE; McMichael AJ
    Immunogenetics; 1983; 17(6):623-35. PubMed ID: 6407986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
    Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
    J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cross-reactive T cell restriction epitopes located on the DR7 beta 1 and DR beta 4 molecules.
    Bismuth G; Gouy H; Karr RW; Debré P
    Hum Immunol; 1990 Jul; 28(3):271-83. PubMed ID: 1695622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse monoclonal anti-Ia antibodies recognize cross-reacting determinants expressed on distinct subsets of human Ia-like cell-surface molecules.
    Birnbaum D; Rohner C; Dubreuil P; Bourgue F; Pierres M; Goridis C
    Mol Immunol; 1983 May; 20(5):511-20. PubMed ID: 6192324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules.
    Karr RW; Hsu SH; Bias WB
    Hum Immunol; 1986 Feb; 15(2):198-210. PubMed ID: 3081469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.
    Sorrentino R; Lillie J; Strominger JL
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3794-8. PubMed ID: 2582424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.